A Study to Identify Strategies for Mitigating Procedural Aerosolization

Overview

About this study

The purpose of this study is to examine the room aerosolization related to various interventions, determine the aerosol clearance of the unique procedure and operation rooms, and assess the impact of aerosol mitigation strategies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age 18-70 years old
No known coronary artery disease, brochospastic disorders or coagulopathies.
Negative COVID-19 screening and molecular testing.
Able to give informed consent.

Exclusion Criteria:

Age under 18 and over 70 years old.
Inability to receive sedation or anesthesia (if required for the procedure).
Emergency procedures.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Navtej Buttar, M.D.	Closed for enrollment	Contact information: Veeravich Jaruvongvanich M.D. (000) 000-0000

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Navtej Buttar, M.D.

Closed for enrollment

Contact information:

Veeravich Jaruvongvanich M.D.

(000) 000-0000

More information

Publications

Publications are currently not available

Clinical Trials